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Dr Philip A. Hayward (Melbourne, Australia). I’d like to
thank the American Association for Thoracic Surgery Committee
for the invitation to discuss this work and also thank Dr Kieser for
supplying me with a draft of the manuscript in a timely fashion.
Dr Kieser, you are to be congratulated on an important study.
You’ve done a sophisticated analysis of your own coronary prac-
tice, and your commitment to arterial grafting and to completeness
of revascularization is impressive.The Journal of Thoracic and CYou state as a limitation that this is a single-surgeon experi-
ence, but in this context this may be 1 of the merits of the study
because it allows us to really tease out the effect of incomplete
revascularization. Other series published can be pools of patients
done by different surgeons, with varying thresholds for grafting
small or poor targets, and it is difficult to tease out the effect
of incomplete revascularization when there have been 2 different
revascularization strategies and thresholds. You have a unifor-
mity of your threshold for revascularization—the same eyes,
the same hands, the same threshold—I think that’s why your
study is unique.
Fractional-flow reserve (FFR) is redefining what we think
needs revascularization now. It’s all about physiology, not anat-
omy, we know that from percutaneous intervention and the
Fractional Flow Reserve versus Angiography for Multivessel
Evaluation study. FFR depends on the volume of distal ante-
grade flow, not just the stenosis. Vessels that are small or
running into scar or that are well collateralized do not have sig-
nificant FFR. About 87% of the vessels you left fall into this
category. I suggest that really your ‘‘incomplete revasculariza-
tion’’ group was in fact functionally completely revascularized
for the most part, and the vessels that you left alone really
were functionally insignificant. And that’s probably why you’ve
not shown any effect on survival from your ‘‘incomplete revas-
cularization’’ and that’s reflected in the lack of a difference in
angina, myocardial infarction, or percutaneous coronary inter-
vention thereafter.
You say that your findings differ from other authors because you
used arterial grafts rather than vein grafts and that you therefore
avoided early vein graft failure. But, of course, you also avoid
the progression of native vessel disease that’s seen primarily after
vein grafts, and it is this progression that can damage the collater-
alization that had been providing protection from the effects of
incomplete revascularization. An all-arterial graft population has
been shown to produce less native vessel disease progression, so
perhaps the collaterals are better preserved and hence your
different findings.
I would like to pose 2 questions: The surprise finding clearly is
the difference in the long-term outcome in the octogenarians who
had incomplete revascularization. Do you really think this is a
different effect of incomplete coronary revascularization in older
people, or is there another factor here—a frailty factor—where
really this was a different pool of frail elderly people where you
lowered your threshold for leaving targets alone, such that really
their poorer survival comes from their frailty rather than the fact
that you decided to leave 1 target?
The second question follows from that. You told us that
incomplete revascularization didn’t affect in-hospital mortality
overall, but was that also true for the octogenarians whose
long-term outcome you say is poorer with incomplete revascu-
larization? Perhaps their long-term outcome is just a reflection
of a turbulent perioperative period. I think that shorter-term
outcome data might influence most surgeons’ practice more
than the long-term survival, because many of us faced with frail
octogenarians are really focused on getting them out of the hos-
pital intact and we tend to lower our horizons. If I’m
faced with that frail octogenarian patient and I want to get
him or her safely through, does complete or incompleteardiovascular Surgery c Volume 147, Number 1 83
Acquired Cardiovascular Disease Kieser et al
A
C
Drevascularization matter in the short term, irrespective of if it
matters in the long term?
Dr Teresa Kieser (Calgary, Alberta, Canada). Your point
regarding FFR is very well taken. Rastan and Fred Mohr had an
article in Circulation in 2009 that spoke to this. They didn’t say
the reason was FFR, but they spoke about vessels that were within
scar, for example. So it didn’t matter if you didn’t completely re-
vascularize them. I think your reason is correct, the FFR would be
insignificant. However, being the bilateral internal mammary ar-
tery graft fanatic that I am, I would still like to invoke the untimely
demise of the vein graft as a mechanism.
With respect to poorer survival coming from surgical frailty or not
wanting to put an older patient through the stress of surgery, I think
the reasons are 2-fold:Operatingon frail people does cause a surgeon
to possibly scale down the operative procedure. But experience has
taught me that when you operate on an 80-year old, everything has
to go correctly. They cannot tolerate the slightest complication the
way a younger patient would. The wheels easily fall off the wagon.84 The Journal of Thoracic and Cardiovascular SurgeIncomplete revascularization in an octogenarian patient perio-
peratively, you are right, we probably should have included this.
There were only 70 patients older than age 80 years, 53 were
incompletely revascularized, so that’s 76%.
The operative mortality was not different. There were 2 out of
23 incompletely revascularized patients who died, and 3 out of
47 of the completely revascularized patients died—a P value
that was insignificant. We looked at the cause of death of these 5
patients: 1 died from fulminant sepsis at another hospital, very
quickly; another had a massive stroke; another died of necrotic
bowel because he had embolized from a calcified aorta (we had
had to perform the procedure on him off-pump and he was a re-
do). The deaths of 2 patients of the 5 were probably due to graft-
ability issues or graft failure. Incomplete revascularization did not
make a difference in these patients. So the answer is if you can get
a patient—an 80-year-old—out of hospital alive and intact with
incomplete revascularization this is better.
Dr Hayward. That’s a great relief. Thank you.ry c January 2014
